Advanced search
Publication Cover
Expert Review of Vaccines Volume 16, 2017 - Issue 1
Submit an article Journal homepage
2,642
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control

B. M. Van MaanenUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The NetherlandsView further author information
,
P. T. de BoerUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The NetherlandsView further author information
,
F. C. K. DolkUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The NetherlandsView further author information
,
A. W. FriedrichDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsView further author information
,
J. C. WilschutDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsView further author information
,
R. PitmanDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;ICON Health Economics and Epidemiology, Oxfordshire, UKView further author information
&
M. J. PostmaUnit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands;Institute of Science in Healthy Aging & healthcaRE (SHARE), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsCorrespondence[email protected]
View further author information
 show all
Pages 1-4 | Received 06 Jun 2016, Accepted 03 Aug 2016, Published online: 19 Aug 2016

References

  • World Health Organization (WHO). Factsheet Influenza (Seasonal). [ cited 2016 May 1]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
  • Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–5096.
  • de Francisco Shapovalova N, Donadel M, Jit M, et al. A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. 2015;33(48):6537–6544.
  • Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force–5. Value Health. 2012;15(6):828–834.
  • Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature. 1985;318(6044):323–329.
  • Jit M, Brisson M. Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics. 2011;29(5):371–386.
  • Postma MJ. Dynamic modeling for pandemic influenza. Expert Rev Vaccines. 2012;11(5):543–546.
  • Thommes EW, Ismaila A, Chit A, et al. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. BMC Infect Dis. 2015;15:465-015-1193-4.
  • Thommes EW, Chit A, Meier GC, et al. Examining Ontario’s universal influenza immunization program with a multi-strain dynamic model. Vaccine. 2014;32(39):5098–5117.
  • Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.
  • Zagheni E, Billari FC, Manfredi P, et al. Using time-use data to parameterize models for the spread of close-contact infectious diseases. Am J Epidemiol. 2008;168(9):1082–1090.
  • Crepey P, de Boer PT, Postma MJ, et al. Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza Other Respir Viruses. 2015;9(Suppl 1):39–46.
  • Reed C, Meltzer MI, Finelli L, et al. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012;30(11):1993–1998.
  • de Boer PT, Crépey P, Pitman RJ, et al. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine in the United States. Value Health. Forthcoming 2016.
  • Clements KM, Meier G, McGarry LJ, et al. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunother. 2014;10(5):1171–1180.
  • Goeyvaerts N, Willem L, Van Kerckhove K, et al. Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. Epidemics. 2015;13:1–9.
  • Fraaij PL, Heikkinen T. Seasonal influenza: the burden of disease in children. Vaccine. 2011;29(43):7524–7528.
  • Hens N, Ayele GM, Goeyvaerts N, et al. Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC Infect Dis. 2009;9:187-2334-9-187.
  • Pitman RJ, Nagy LD, Sculpher MJ. Cost-effectiveness of childhood influenza vaccination in England and Wales: results from a dynamic transmission model. Vaccine. 2013;31(6):927–942.
  • Thorrington D, Jit M, Eames K. Targeted vaccination in healthy school children – can primary school vaccination alone control influenza? Vaccine. 2015;33(41):5415–5424.
  • Damm O, Eichner M, Rose MA, et al. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ. 2015;16(5):471–488. doi:10.1007/s10198-014-0586-4.
  • Rose MA, Damm O, Greiner W, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014;14:40-2334-14-40.
  • Vynnycky E, Pitman R, Siddiqui R, et al. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine. 2008;26(41):5321–5330.
  • De Boer PT, Frederix GW, Feenstra TL, et al. Unremarked or unperformed? Systematic review on reporting of validation efforts of health economic decision models in seasonal influenza and early breast cancer. Pharmacoeconomics. 2016. doi:10.1007/s40273-016-0410-3
  • Sander B, Nizam A, Garrison LP Jr, et al. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health. 2009;12(2):226–233.
  • Chit A, Roiz J, Briquet B, et al. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors. Vaccine. 2015;33(5):734–741.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.